📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%? (2019)

First Author: Lumbers RT

Attributed to: 'Unlocking therapeutic innovation in heart failure through genomic data science funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/heartjnl-2018-313855

PubMed Identifier: 31345952

Publication URI: http://europepmc.org/abstract/MED/31345952

Type: Journal Article/Review

Volume: 105

Parent Publication: Heart (British Cardiac Society)

Issue: 20

ISSN: 1355-6037